Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD3199 vs Formoterol in COPD
NCT00929708Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of AZD3199 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jun 2009; status: completed.
02
Drugs
AZD3199
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00929708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929708.